These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 2654643)
1. Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B. Griffin GE; Leung K; Folks TM; Kunkel S; Nabel GJ Nature; 1989 May; 339(6219):70-3. PubMed ID: 2654643 [TBL] [Abstract][Full Text] [Related]
2. Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer Cells. Dimapasoc M; Moran JA; Cole SW; Ranjan A; Hourani R; Kim JT; Wender PA; Marsden MD; Zack JA Pathog Immun; 2024; 9(1):108-137. PubMed ID: 38765786 [TBL] [Abstract][Full Text] [Related]
3. Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure. Duggan NN; Dragic T; Chanda SK; Pache L Viruses; 2023 Dec; 15(12):. PubMed ID: 38140676 [TBL] [Abstract][Full Text] [Related]
4. HIV-1 Gag co-localizes with euchromatin histone marks at the nuclear periphery. Chang J; Parent LJ J Virol; 2023 Dec; 97(12):e0117923. PubMed ID: 37991367 [TBL] [Abstract][Full Text] [Related]
5. Development trends of immune activation during HIV infection in recent three decades: a bibliometric analysis based on CiteSpace. Gong K; Lai Y Arch Microbiol; 2023 Jul; 205(8):283. PubMed ID: 37432538 [TBL] [Abstract][Full Text] [Related]
6. Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy. Tang Y; Chaillon A; Gianella S; Wong LM; Li D; Simermeyer TL; Porrachia M; Ignacio C; Woodworth B; Zhong D; Du J; de la Parra Polina E; Kirchherr J; Allard B; Clohosey ML; Moeser M; Sondgeroth AL; Whitehill GD; Singh V; Dashti A; Smith DM; Eron JJ; Bar KJ; Chahroudi A; Joseph SB; Archin NM; Margolis DM; Jiang G J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37317962 [TBL] [Abstract][Full Text] [Related]
7. Variation in blood microbial lipopolysaccharide (LPS) contributes to immune reconstitution in response to suppressive antiretroviral therapy in HIV. Luo Z; Health SL; Li M; Yang H; Wu Y; Collins M; Deeks SG; Martin JN; Scott A; Jiang W EBioMedicine; 2022 Jun; 80():104037. PubMed ID: 35500539 [TBL] [Abstract][Full Text] [Related]
8. U1 and OM10.1. Myeloid Cell Lines as Surrogate Models of Reversible Proviral Latency. Poli G Methods Mol Biol; 2022; 2407():17-28. PubMed ID: 34985654 [TBL] [Abstract][Full Text] [Related]
9. xCT/SLC7A11 antiporter function inhibits HIV-1 infection. Rabinowitz J; Sharifi HJ; Martin H; Marchese A; Robek M; Shi B; Mongin AA; de Noronha CMC Virology; 2021 Apr; 556():149-160. PubMed ID: 33631414 [TBL] [Abstract][Full Text] [Related]
10. Balance between Retroviral Latency and Transcription: Based on HIV Model. Pluta A; Jaworski JP; Cortés-Rubio CN Pathogens; 2020 Dec; 10(1):. PubMed ID: 33383617 [TBL] [Abstract][Full Text] [Related]
18. EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment. Gu CJ; Borjabad A; Hadas E; Kelschenbach J; Kim BH; Chao W; Arancio O; Suh J; Polsky B; McMillan J; Edagwa B; Gendelman HE; Potash MJ; Volsky DJ PLoS Pathog; 2018 Jun; 14(6):e1007061. PubMed ID: 29879225 [TBL] [Abstract][Full Text] [Related]
19. What do we measure when we measure cell-associated HIV RNA. Pasternak AO; Berkhout B Retrovirology; 2018 Jan; 15(1):13. PubMed ID: 29378657 [TBL] [Abstract][Full Text] [Related]
20. Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral Reservoirs. Pasquereau S; Kumar A; Herbein G Viruses; 2017 Mar; 9(4):. PubMed ID: 28358311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]